Moroccan Senate Committee Endorses Comprehensive Drug Law Revisions
On June 22, 2026, the Education, Cultural Affairs, and Social Committee of the Moroccan Senate voted in favor of Bill No. 27.26, which seeks to amend and enhance the existing Drug and Pharmacy Code (Law No. 17.04). This legislative move aims to align Morocco's legal framework with international standards in the pharmaceutical sector, thereby strengthening the roles of the Moroccan Agency for Medicines and Health Products. The committee meeting was attended by the Minister of Health and Social Protection, Amin Tahraoui, who emphasized the government's continuous efforts to improve national regulations in line with global practices.
The proposed law introduces significant updates to the existing drug regulations, focusing on enhancing the mechanisms for the organization and monitoring of medicines and health products. These modifications are designed to ensure the safety, efficacy, and quality of pharmaceuticals available in Morocco. Among the key provisions of the new legal framework is the mandatory appointment of a pharmacovigilance officer within pharmacies, which is aimed at improving drug safety monitoring. Furthermore, healthcare professionals will be required to report any adverse drug reactions, facilitating better oversight of pharmaceutical safety.
One of the most notable features of Bill No. 27.26 is the establishment of a national pharmacovigilance system. This system is intended to systematically monitor and evaluate adverse drug effects, assess risks associated with drug use, and implement necessary preventive measures. In doing so, the law aims to enhance public health protection and improve the safety of drug usage across the country. Additionally, the legislation establishes clear responsibilities within pharmacies for tracking drug safety, ensuring ongoing coordination with the Moroccan Agency for Medicines and Health Products, and promoting effective responses to drug-related risks.
It is important to note that this bill was previously endorsed by the Social Sectors Committee of the House of Representatives before being presented for discussion and approval by the Senate Committee. The passage of this law marks a significant step toward advancing Morocco's pharmaceutical regulatory framework and demonstrates the government's commitment to safeguarding public health.
As reported by hespress.com.
